Senores Pharmaceuticals Share Price
1402.60+0.00 (+0.00%)
+96.91% past 1 Year
Corporate filings & documents
Announcements
We are pleased to announce that the USFDA has successfully completed its inspection at the manufacturing facility of Apnar Pharma Private Limited
1 week agoWe are pleased to announce that the USFDA has successfully completed its inspection at the manufacturing facility of Apnar Pharma Private Limited
1 week agoWe are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.
1 week agoWe are submitting herewith the Corrigendum to the Annual Report of the Company for the financial year 2025-26.
1 week agoWe are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.
2 weeks agoWe are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.
2 weeks agoWe are submitting herewith the copy of Business Responsibility and Sustainability Report of the Company for the financial year 2025-26.
2 weeks agoWe are submitting herewith the copy of Business Responsibility and Sustainability Report of the Company for the financial year 2025-26.
2 weeks agoWe are submitting herewith the Annual Report of the Company for the financial year 2025-26.
2 weeks agoWe are submitting herewith the Annual Report of the Company for the financial year 2025-26.
2 weeks agoWe are submitting herewith the notice convening the 9th Annual general Meeting of the Company and Annual Report for the financial year 2025-26
2 weeks agoWe are submitting herewith the notice convening the 9th Annual general Meeting of the Company and Annual Report for the financial year 2025-26
2 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on September 02 2026
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on September 02 2026
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Report for the forthcoming Annual General Meeting of the Company
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding copy of newspaper publication for pre dispatch of Annual Report for the forthcoming Annual General Meeting of the Company
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Independent Director
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Independent Director
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding appointment of Company Secretary and Compliance Officer of the Company
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding appointment of Company Secretary and Compliance Officer of the Company
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Subsidiary Company in Canada
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Subsidiary Company in Canada
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Wholly owned subsidiary in Mexico
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding proposed incorporation of Wholly owned subsidiary in Mexico
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange about Outcome of Board Meeting held on August 26 2026
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange about Outcome of Board Meeting held on August 26 2026
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited Subsidiary of the Company from ICICI Bank Limited
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited Subsidiary of the Company from ICICI Bank Limited
3 weeks agoSenores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on August 25 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Analyst/ Institutional Investor Meet scheduled to be held on August 25 2026
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhananjay Barot
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dhananjay Barot
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashokkumar Vijaysinh Barot
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ashokkumar Vijaysinh Barot
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding the Scrutinzer Report dated August 04 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Postal Ballot
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday July 27 2026 for Q1FY27.
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Transcript of Earnings Conference Call held on Monday July 27 2026 for Q1FY27.
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Newspaper Publication Extracts of Unaudited Financial Results of the Company for quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Audio recording of Earnings Conference Call for the quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Audio recording of Earnings Conference Call for the quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible equity warrants for the quarter ended on June 30 2026.
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible equity warrants for the quarter ended on June 30 2026.
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for quarter ended June 30 2026
1 month agoSenores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for quarter ended June 30 2026
1 month agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
Jan 2026
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025